Perioperative tumor growth acceleration is associated with inflammatory pathway activation. Non-steroidal anti-inflammatory drugs, particularly ketorolac, are a promising way to improve patient outcome.
|Translated title of the contribution||A single intraoperative dose of original ketorolac to prevent cancer recurrence: Is that too simple?|
|Number of pages||5|
|Publication status||Published - Jun 2014|
- postoperative cancer recurrence